The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
Open accessAbstract
Summary A systematic characterization of the genetic alterations driving ALCLs has not been performed. By integrating massive sequencing strategies, we provide a comprehensive characterization of driver genetic alterations (somatic point mutations, copy number alterations, and gene fusions) in ALK− ALCLs. We identified activating mutations of JAK1 and/or STAT3 genes in ∼20% of 155 ALK− ALCLs and demonstrated that 38% of systemic ALK− ALCLs displayed double lesions. Recurrent chimeras combining a transcription factor (NFkB2 or NCOR2) with a tyrosine kinase (ROS1 or TYK2) were also discovered in WT JAK1/STAT3 ALK− ALCL. All these aberrations lead to the constitutive activation of the JAK/STAT3 pathway, which was proved oncogenic. Consistently, JAK/STAT3 pathway inhibition impaired cell growth in vitro and in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International T-Cell Lymphoma Project (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.4558 · Cited by 2,108
Oncogenically active MYD88 mutations in human lymphoma
Ngo, V. N., Young, R. M., Schmitz, R., Jhavar, S., Xiao, W., Lim, K.-H., Kohlhammer, H., Xu, W., Yang, Y., Zhao, H., et al. (2011) · Nature · doi:10.1038/nature09671 · Cited by 1,512
Self-citationSavage, K. J., Harris, N. L., Vose, J. M., Ullrich, F., Jaffe, E. S., Connors, J. M., Rimsza, L., Pileri, S. A., Chhanabhai, M., Gascoyne, R. D., et al. (2008) · Blood · doi:10.1182/blood-2008-01-134270 · Cited by 863
Self-citationSomatic STAT3 Mutations in Large Granular Lymphocytic Leukemia
Koskela, H. L. M., Eldfors, S., Ellonen, P., van Adrichem, A. J., Kuusanmäki, H., Andersson, E. I., Lagström, S., Clemente, M. J., Olson, T., Jalkanen, S. E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114885 · Cited by 777
Shern, J. F., Chen, L., Chmielecki, J., Wei, J. S., Patidar, R., Rosenberg, M., Ambrogio, L., Auclair, D., Wang, J., Song, Y. K., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0639 · Cited by 756
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas
Palomero, T., Couronné, L., Khiabanian, H., Kim, M.-Y., Ambesi-Impiombato, A., Perez-Garcia, A., Carpenter, Z., Abate, F., Allegretta, M., Haydu, J. E., et al. (2014) · Nature Genetics · doi:10.1038/ng.2873 · Cited by 619
Self-citationFrequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
Rebouissou, S., Amessou, M., Couchy, G., Poussin, K., Imbeaud, S., Pilati, C., Izard, T., Balabaud, C., Bioulac-Sage, P., & Zucman-Rossi, J. (2009) · Nature · doi:10.1038/nature07475 · Cited by 477
Parrilla Castellar, E. R., Jaffe, E. S., Said, J. W., Swerdlow, S. H., Ketterling, R. P., Knudson, R. A., Sidhu, J. S., Hsi, E. D., Karikehalli, S., Jiang, L., et al. (2014) · Blood · doi:10.1182/blood-2014-04-571091 · Cited by 472
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target
Chiarle, R., Simmons, W. J., Cai, H., Dhall, G., Zamo, A., Raz, R., Karras, J. G., Levy, D. E., & Inghirami, G. (2005) · Nature Medicine · doi:10.1038/nm1249 · Cited by 442
Self-citationSTAT3 SIGNALING: Anticancer Strategies and Challenges
Johnston, P. A., & Grandis, J. R. (2011) · Molecular Interventions · doi:10.1124/mi.11.1.4 · Cited by 406
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma
Odejide, O., Weigert, O., Lane, A. A., Toscano, D., Lunning, M. A., Kopp, N., Kim, S., van Bodegom, D., Bolla, S., Schatz, J. H., et al. (2014) · Blood · doi:10.1182/blood-2013-10-531509 · Cited by 398
Self-citationNeri, A., Chang, C.-C., Lombardi, L., Salina, M., Corradini, P., Maiolo, A. T., Chaganti, R. S. K., & Dalla-Favera, R. (1991) · Cell · doi:10.1016/0092-8674(91)90285-7 · Cited by 390
The Role of Corepressors in Transcriptional Regulation by Nuclear Hormone Receptors
Privalsky, M. L. (2004) · Annual Review of Physiology · doi:10.1146/annurev.physiol.66.032802.155556 · Cited by 324
Tyrosine kinase gene rearrangements in epithelial malignancies
Shaw, A. T., Hsu, P. P., Awad, M. M., & Engelman, J. A. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3612 · Cited by 292
Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia
Kiel, M. J., Velusamy, T., Rolland, D., Sahasrabuddhe, A. A., Chung, F., Bailey, N. G., Schrader, A., Li, B., Li, J. Z., Ozel, A. B., et al. (2014) · Blood · doi:10.1182/blood-2014-03-559542 · Cited by 255
Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas
Pilati, C., Amessou, M., Bihl, M. P., Balabaud, C., Van Nhieu, J. T., Paradis, V., Nault, J. C., Izard, T., Bioulac-Sage, P., Couchy, G., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110283 · Cited by 242
Lupardus, P. J., Ultsch, M., Wallweber, H., Bir Kohli, P., Johnson, A. R., & Eigenbrot, C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401180111 · Cited by 229
Chrencik, J. E., Patny, A., Leung, I. K., Korniski, B., Emmons, T. L., Hall, T., Weinberg, R. A., Gormley, J. A., Williams, J. M., Day, J. E., et al. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.05.020 · Cited by 227
A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development
Yin, X., DeWille, J. W., & Hai, T. (2008) · Oncogene · doi:10.1038/sj.onc.1210861 · Cited by 209
Targeting the tumor microenvironment: JAK-STAT3 signaling
Bournazou, E., & Bromberg, J. (2013) · JAK-STAT · doi:10.4161/jkst.23828 · Cited by 189
Piva, R., Agnelli, L., Pellegrino, E., Todoerti, K., Grosso, V., Tamagno, I., Fornari, A., Martinoglio, B., Medico, E., Zamò, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.9759 · Cited by 165
Self-citationJerez, A., Clemente, M. J., Makishima, H., Rajala, H. L. M., Gómez‐Seguí, I., Olson, T. L., McGraw, K. L., Przychodzen, B. P., Kulasekararaj, A. G., Afable, M. G., et al. (2013) · Blood · doi:10.1182/blood-2013-04-494930 · Cited by 157
TYK2–STAT1–BCL2 Pathway Dependence in T-cell Acute Lymphoblastic Leukemia
Sanda, T., Tyner, J. W., Gutiérrez, A., Ngo, V. N., Glover, J., Chang, B. H., Yost, A., Ma, W., Fleischman, A. G., Zhou, W., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0504 · Cited by 146
Zhang, L., Yang, J., Qian, J., Li, H., Romaguera, J. E., Kwak, L. W., Wang, M. L., & Yi, Q. (2012) · Blood · doi:10.1182/blood-2012-04-424630 · Cited by 123
PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma
Boi, M., Rinaldi, A., Kwee, I., Bonetti, P., Todaro, M., Tabbò, F., Piva, R., Rancoita, P. M. V., Matolcsy, A., Tímár, B., et al. (2013) · Blood · doi:10.1182/blood-2013-04-497933 · Cited by 119
Self-citationTargeted therapy of multiple myeloma based upon tumor-microenvironmental interactions
Anderson, K. C. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.01.024 · Cited by 112
A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders
Velusamy, T., Kiel, M. J., Sahasrabuddhe, A. A., Rolland, D. C. M., Dixon, C. A., Bailey, N. G., Betz, B. L., Brown, N. A., Hristov, A. C., Wilcox, R. A., et al. (2014) · Blood · doi:10.1182/blood-2014-07-588434 · Cited by 106
Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia
Bellanger, D., Jacquemin, V., Chopin, M., Pierron, G., Bernard, O., Ghysdael, J., & Stern, M. (2013) · Leukemia · doi:10.1038/leu.2013.271 · Cited by 105
Comprehensive review of JAK inhibitors in myeloproliferative neoplasms
Sonbol, M. B., Firwana, B., Zarzour, A., Morad, M. L., Rana, V., & Tiu, R. V. (2012) · Therapeutic Advances in Hematology · doi:10.1177/2040620712461047 · Cited by 98
Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck Cancer
Li, R. Q., You, S., Hu, Z., Chen, Z. G., Sica, G., Khuri, F. R., Curran, W. J., Shin, D. M., & Deng, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074670 · Cited by 88
Ohgami, R. S., Ma, L., Merker, J. D., Martinez, B., Zehnder, J. L., & Arber, D. A. (2013) · Leukemia · doi:10.1038/leu.2013.104 · Cited by 75
Abate, F., Zairis, S., Ficarra, E., Acquaviva, A., Wiggins, C. H., Frattini, V., Lasorella, A., Iavarone, A., Inghirami, G., & Rabadán, R. (2014) · BMC Systems Biology · doi:10.1186/s12918-014-0097-z · Cited by 71
Self-citationA novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation
Abate, F., Todaro, M., van der Krogt, J.-A., Boi, M., Landra, I., Machiorlatti, R., Tabbò, F., Messana, K., Abele, C., Barreca, A., et al. (2014) · Leukemia · doi:10.1038/leu.2014.347 · Cited by 53
Self-citationThe EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1
Voena, C., Giacomo, F. D., Panizza, E., D’Amico, L., Boccalatte, F. E., Pellegrino, E., Todaro, M., Recupero, D., Tabbò, F., Ambrogio, C., et al. (2013) · Oncogenesis · doi:10.1038/oncsis.2013.7 · Cited by 36
Self-citation
Cited by
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., Advani, R., Ghielmini, M., Salles, G. A., Zelenetz, A. D., et al. (2016) · Blood · doi:10.1182/blood-2016-01-643569 · Cited by 7,831
Self-citationMechanisms and consequences of Jak–STAT signaling in the immune system
Villarino, A. V., Kanno, Y., & O'Shea, J. J. (2017) · Nature Immunology · doi:10.1038/ni.3691 · Cited by 1,221
Wright, G. W., Huang, D. W., Phelan, J. D., Coulibaly, Z. A., Roulland, S., Young, R. M., Wang, J. Q., Schmitz, R., Morin, R. D., Tang, J., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.015 · Cited by 1,169
Cytokines in Cancer Immunotherapy
Waldmann, T. A. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028472 · Cited by 507
Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death
Garcia-Bermudez, J., Baudrier, L., Bayraktar, E. C., Shen, Y., La, K., Guarecuco, R., Yucel, B., Fiore, D., Tavora, B., Freinkman, E., et al. (2019) · Nature · doi:10.1038/s41586-019-0945-5 · Cited by 424
Self-citation
Metadata
- Authors
- Crescenzo, R., Abate, F., Lasorsa, E., Tabbo’, F., Gaudiano, M., Chiesa, N., Di Giacomo, F., Spaccarotella, E., Barbarossa, L., Ercole, E., Todaro, M., Boi, M., Acquaviva, A., Ficarra, E., Novero, D., Rinaldi, A., Tousseyn, T., Rosenwald, A., Kenner, L., Cerroni, L., Tzankov, A., Ponzoni, M., Paulli, M., Weisenburger, D., Chan, W. C., Iqbal, J., Piris, M. A., Zamo’, A., Ciardullo, C., Rossi, D., Gaidano, G., Pileri, S., Tiacci, E., Falini, B., Shultz, L. D., Mevellec, L., Vialard, J. E., Piva, R., Bertoni, F., Rabadan, R., & Inghirami, G.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 27
- Issue
- 4
- Pages
- 516-532
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W1968235930
- Cited by
- 443
- References
- 34
- FWCI
- 32.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.